scispace - formally typeset
S

Salim Yusuf

Researcher at McMaster University

Publications -  6
Citations -  1190

Salim Yusuf is an academic researcher from McMaster University. The author has contributed to research in topics: Discovery and development of direct thrombin inhibitors & Genome-wide association study. The author has an hindex of 5, co-authored 6 publications receiving 1100 citations. Previous affiliations of Salim Yusuf include Hamilton General Hospital & Population Health Research Institute.

Papers
More filters
Journal ArticleDOI

A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease

John F. Peden, +110 more
- 01 Apr 2011 - 
TL;DR: Genome-wide association studies have identified 11 common variants convincingly associated with coronary artery disease (CAD), a modest number considering the apparent heritability of CAD(8) as mentioned in this paper.
Journal ArticleDOI

Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid Loci

Folkert W. Asselbergs, +184 more
TL;DR: This large meta-analysis of lipid phenotypes with the use of a dense gene-centric approach identified multiple SNPs not previously described in established lipid genes and several previously unknown loci, suggesting that a focused genotyping approach can further increase the understanding of heritability of plasma lipids.
Journal ArticleDOI

Gene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations

Sachiko Yoneyama, +85 more
TL;DR: Functional analysis using ENCODE and eQTL databases revealed that several of these loci are in regulatory regions or regions with differential expression in adipose tissue, supporting an already established sexual dimorphism of central adiposity-related genetic variants.
Journal ArticleDOI

Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention.

TL;DR: After adjustment for baseline differences and propensity to undergo early PCI, DTIs appeared to be more effective than heparin in reducing death or re-infarction among patients undergoing early PCI.